ACTEMRA 400mg/20mL (Tocilizumab) is an intravenous monoclonal antibody that blocks IL-6 receptors to treat inflammatory conditions such as rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis, cytokine release syndrome, and severe COVID-19 pneumonia.
